Jain Global’s Bristol-Myers Squibb BMY Stock Holding History

Jain Global’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-103,042	Closed	-$6.25M	–	1755
2026 Q1	$6.25M	Buy	+103,042	New	+$6.01M	0.03%	438
2025 Q1	–	Sell	-226,794	Closed	-$12.8M	–	1084
2024 Q4	$12.8M	Buy	+226,794	New	+$12.7M	0.38%	58

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jain Global's BMY Position: Q2 2026 in Review

Jain Global sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 103,042 shares — an estimated $6.25M sold.

Jain Global first reported a position in BMY in Q4 2024 and held it in 2 quarters. The position peaked at $12.8M in Q4 2024. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Jain Global reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
Jain Global sold 103,042 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.25M.
Jain Global first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 2 quarters.
Jain Global's Bristol-Myers Squibb position peaked at $12.8M in Q4 2024.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.